在炎症性肠道疾病中降低牛蛋白血清水平
Rachele Frascatani1, Adelaide Mattogno2, Andrea Iannucci3
1Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Nutrients
|June 19, 2024
概括
在患有炎症性肠道疾病 (IBD) 的患者中,血清 taurine 水平显著降低,包括性结肠炎 (UC) 和克罗恩氏病.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 营养科学 营养科学
背景情况:
- 氨酸是一种半必需的微量营养素,具有已知的抗炎性质.
- 口服牛氨酸的使用在减少小鼠实验性结肠炎方面表现出有效性.
- 炎症性肠病 (IBD) 包括胃肠道的慢性炎症状况,包括性结肠炎 (UC) 和克罗恩病 (CD).
研究的目的:
- 调查在被诊断患有IBD的患者中,循环中的 taurine 水平是否发生变化.
- 为了比较IBD亚型 (UC和CD) 和健康对照之间的 taurine 度.
- 探索IBD患者的氨酸水平,疾病活性,年龄和营养因素之间的关系.
主要方法:
- 从92名IBD患者 (46名UC,46名CD) 和33名健康对照人群中采集了血清样本.
- 使用商业ELISA套件量化氨酸度.
- 进行了统计分析,以比较不同组的 taurine 水平,并评估与临床参数的相关性.
主要成果:
- 与健康对照人群相比,UC和CD患者的血清氨酸水平显著降低.
- 在UC和CD患者之间没有观察到氨酸水平的显著差异.
- 氨酸水平随着年龄的增长而降低,但在IBD患者中没有降低;年轻的IBD患者 (<50岁) 呈现出减少的氨酸.
- IBD患者的氨酸水平与BMI或氨酸丰富的营养素摄入量无关.
- 与缓解期UC相比,活性UC疾病与明显较低的 taurine 水平相关.
结论:
- IBD的特点是血清氨酸的缺乏.
- 血清 taurine 缺乏似乎与疾病活动相关,特别是在性结肠炎.
- 这些发现表明牛在病理生理学中或作为IBD活动的生物标志物的潜在作用.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
01:30Inflammatory Bowel Disease II: Crohn's Disease
213
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
213
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
161
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
161
01:29Drugs for Treatment of Ulcerative Colitis in IBD
135
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135
01:29Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125